Search bioRxiv⌕ Search

Biology subjects

Lau, K. H. W. J.

Publications and source records attributed to Lau, K. H. W. J..

2 recordsLinked to original sources

Numerical optimization of microfluidic vortex shedding for genome editing human primary T cells using machine learning

Microfluidic vortex shedding (VS) can rapidly deliver mRNA to T cells with high yield. The mechanistic underpinning of VS intracellular delivery remains undefined and VS-Cas9 genome editing requires further studies. Herein, we evaluated a series of VS devices containing splitter plates to attenuate vortex shedding and understand the contribution of computed force and frequency on efficiency and viability. We then selected a VS design to knockout the expression of the endogenous T cell receptor in primary human T cells via delivery of CRISPR-Cas9 ribonucleoprotein (RNP) with and without brief exposure to an electric field (eVS). VS alone resulted in an equivalent yield of genome-edited T cells relative to electroporation with improved cell quality. A 1.8-fold increase in editing efficiency was demonstrated with eVS with negligible impact on cell viability. Cumulatively, these results demonstrate the utility of VS and eVS for genome editing human primary T cells with Cas9 RNPs.

immunology↗

Intracellular delivery of mRNA to human primary T cells with microfluidic vortex shedding

Intracellular delivery of functional macromolecules, such as DNA and RNA, across the cell membrane and into the cytosol, is a critical process in both biology and medicine. Herein, we develop and use microfluidic chips containing post arrays to induce microfluidic vortex shedding, or VS, for cell membrane poration that permits delivery of mRNA into primary human T lymphocytes. We demonstrate transfection with VS by delivery of a 996-nucleotide mRNA construct encoding enhanced green fluorescent protein (EGFP) and assessed transfection efficiencies by quantifying levels of EGFP protein expression. We achieved high transfection efficiency (63.6 {+/-} 3.44% EGFP+ viable cells) with high cell viability (77.3 {+/-} 0.58%) and recovery (88.7 {+/-} 3.21%) in CD3+ T cells 19 hrs after VS processing. Importantly, we show that processing cells via VS does not negatively affect cell growth rates or alter cell states. We also demonstrate processing speeds of greater than 2.0 x 106 cells s-1 at volumes ranging from 0.1 to 1.5 milliliters. Altogether, these results highlight the use of VS as a rapid and gentle delivery method with promising potential to engineer primary human cells for research and clinical applications.

bioengineering↗